Clinical Trial Update: BENLYSTA® Special Drug Use Investigation

View source ↗

Summary

This entry notes the completion of GlaxoSmithKline's Special Drug Use Investigation for BENLYSTA (belimumab) in systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED